Next Article in Journal
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector
Next Article in Special Issue
A Data-Driven Digital Application to Enhance the Capacity Planning of the COVID-19 Vaccination Process
Previous Article in Journal
Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines
Previous Article in Special Issue
COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
 
 
Article

Article Versions Notes

Vaccines 2021, 9(10), 1130; https://doi.org/10.3390/vaccines9101130
Action Date Notes Link
article xml file uploaded 4 October 2021 12:59 CEST Original file -
article xml uploaded. 4 October 2021 12:59 CEST Update https://www.mdpi.com/2076-393X/9/10/1130/xml
article pdf uploaded. 4 October 2021 12:59 CEST Version of Record https://www.mdpi.com/2076-393X/9/10/1130/pdf
article html file updated 4 October 2021 13:00 CEST Original file -
article html file updated 4 October 2021 13:01 CEST Update -
article html file updated 30 July 2022 09:16 CEST Update https://www.mdpi.com/2076-393X/9/10/1130/html
Back to TopTop